Thomas Delvin
Vice President, Head of Global Clinical Development, LEO Pharma at LEO Pharma | Holbæk, Region Zealand, Denmark
Thomas Delvin’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Vice President, Head of Global Clinical Development, LEO Pharma at LEO Pharma in June 2023 - Present
Head of Clinical Science at Pharmacosmos in October 2025 - Present
Sr. Director, Head of Medical Department & Pharmacoepidemiology, Global Clinical Development at LEO Pharma in November 2022 - June 2023
Director Biostatistics & Pharmacoepidemiology at LEO Pharma in October 2019 - November 2022
Head of Section, Section of Pharmacoepidemiology, Medical Department at LEO Pharma in March 2017 - October 2019
Senior Global Medical Science Lead, Medical Sciences & Safety at LEO Pharma in May 2016 - March 2017
International Medical Manager, Medical & Science, Liraglutide & Obesity at Novo Nordisk in September 2014 - May 2016
Global Scientific Adviser at LEO Pharma A/S in November 2013 - October 2014
Senior Medical Adviser, Global Clinical Development Team Leader at Takeda Pharmaceuticals in January 2012 - December 2013
Senior Medical Adviser, Clinical Development at Nycomed in July 2011 - December 2012
Medical Adviser Clinical Development at Nycomed in May 2010 - July 2011
Medical adviser at Nycomed in January 2007 - December 2010
Int. Medical Adviser at Nycomed Pharma in November 2007 - May 2010
IT support at University of Southern Denmark in January 1999 - December 2005
Syddansk Universitet - University of Southern Denmark, MD, July 1998 to July 2026
Hibernia College, M. Sc., July 2026
NLP-Huset, NLP, July 2026
Pharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anaemia. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. Founded in 1965 and headquartered in Denmark, our team is made up of more than 700 specialists across the UK, Ireland, the Nordics, Germany, the USA, Canada, and China. Learn more about Pharmacosmos at www.pharmacosmos.com.
Discover more about LEO Pharma
Senior Manager Customer Service & Logistics hos PHARMACOSMOS
Senior Manager, Customer Service & Logistics at Pharmacosmos
(August 2024 – Present)
Senior Director, Global Medical Affairs
Lecturer at Atrium Copenhagen
(May 2026 – May 2026)
Director of QA
Senior Manager at Novo Nordisk
(May 2026 – May 2026)
Vice President, Global Medical Affairs at Pharmacosmos
Vice President, Global Medical Affairs at Pharmacosmos
(May 2024 – Present)
Group Financial Controller at Pharmacosmos
Group Financial Controller at Pharmacosmos
(March 2025 – Present)
Senior International Medical Director, Global Medical Affairs at Pharmacosmos
International Medical Director at Pharmacosmos
(May 2019 – Present)
What is Thomas Delvin email address?
Email Thomas Delvin at [email protected] and [email protected]. This email is the most updated Thomas Delvin's email found in 2026.
How to contact Thomas Delvin?
To contact Thomas Delvin send an email to [email protected] or [email protected]. (updated on November 28, 2025)
What company does Thomas Delvin work for?
Thomas Delvin works for LEO Pharma.
What is Thomas Delvin's role at LEO Pharma?
Thomas Delvin is Vice President, Head of Global Clinical Development, LEO Pharma
What industry does Thomas Delvin work in?
Thomas Delvin works in the Pharmaceuticals industry.
